Mycophenolate mofetil in renal graft recipients with increased immune risk of graft loss.
Boratyńska
Maria
M
Department of Nephrology and Transplant Medicine, Medical University of Wrocław, uk. Tragutta 57/59, 50-417 Wrocław, Poland.
Magott
M
M
Klinger
M
M
Smolska
D
D
Rychlewska
B
B
Myszka
K
K
Szepietowski
T
T
Szyber
P
P
Patrzalek
D
D
D000328:Adult; D002102:Cadaver; D004359:Drug Therapy, Combination; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D012086:Reoperation / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D014019:Tissue Donors; D017211:Treatment Failure
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid